TeleCure Fires Executive For “Microaggression”
The world of small cap continues to amaze. It was announced this evening that TeleCure Technologies (CSE: TELE) has fired
Read more
Healthcare
Ventripoint Receives Further Funding From National Research Council of Canada
Ventripoint Diagnostics (TSXV: VPT) this morning had a brief release, indicating the firm has received further research funding. The latest
Read more
Revive Therapeutics Includes Treating Omicron Variant In Bucillamine Research
Revive Therapeutics (CSE: RVV) announced today that it is expanding its research on oral drug Bucillamine. The firm decided to include
Read more
Skylight Health Sees Minimal Interest For Preferred Shares, Offering Pegged At Just US$5.8 Million
It appears that there is little interest for Skylight Health’s (TSXV: SLHG) previously proposed offering of Series A redeemable perpetual
Read more
CloudMD: Canaccord Reiterates $3.00 Price Target After Q3 Results
On November 29th, CloudMD Software & Services Inc. (TSXV: DOC) announced its third quarter financial results. This is the first
Read more
CloudMD Hits $39.2 Million In Revenue, $4.3 Million Net Loss In Q3 2021
CloudMD Software & Services Inc. (TSXV: DOC) released on Monday its Q3 2021 financial results which saw the company post
Read more
Leveljump Takes Minority Stake In Radiology Service Provider
Leveljump Healthcare (TSXV: JUMP) is looking to expand its current portfolio. The company last night announced a minority investment in
Read more
Empower Clinics Posts Revenues Of $0.4 Million For Q3
Empower Clinics (CSE: CBDT) this morning reported its third quarter financial results, posting revenues of $0.4 million for the three
Read more
CloudMD: Canaccord Drops Price Target To $3.00 Following MindBeacon Deal
On November 15th, CloudMD Software & Services (TSXV: DOC) announced that they would be acquiring MindBeacon Holdings (TSX: MBCN) for
Read more
Cognetivity’s Brain Health Monitoring App – The Daily Dive
On this Daily Dive episode, Cassandra talks to Dr. Sina Habibi, CEO of Cognetivity Neurosciences (CSE: CGN). He joins us
Read more